Libing Zhu

Dr. Libing Zhu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2024 in Cancers
Verified
Journal Article
Open access
PDF file
LZLibing Zhu
Libing Zhu
YRYi Rong
Yi Rong
LMLisa A. McGee
Lisa A. McGee
JRJean-Claude M. Rwigema
Jean-Claude M. Rwigema
SPSamir H. Patel
Samir H. Patel
Purpose: This study aimed to develop a retrained large language model (LLM) tailored to the needs of HN cancer patients treated with radiotherapy, with emphasis on symptom management and survivorship care. Methods: A comprehensive external database was curated for training ChatGPT-4, integrating expert-identified consensus guidelines on supportive care for HN patients and correspondences from physicians and nurses within our institution’s electronic medical records for 90 HN patients. The performance of our model was evaluated using 20 patient post-treatment inquiries that were then assessed by three Board certified radiation oncologists (RadOncs). The rating of the model was assessed on a scale of 1 (strongly disagree) to 5 (strongly agree) based on accuracy, clarity of response, completeness s, and relevance. Results: The average scores for the 20 tested questions were 4.25 for accuracy, 4.35 for clarity, 4.22 for completeness, and 4.32 for relevance, on a 5-point scale. Overall, 91.67% (220 out of 240) of assessments received scores of 3 or higher, and 83.33% (200 out of 240) received scores of 4 or higher. Conclusion: The custom-trained model demonstrates high accuracy in providing support to HN patients offering evidence-based information and guidance on their symptom management and survivorship care.

10 June 2025 in Cancers
Verified
Journal Article
Open access
PDF file
LZLibing Zhu
Libing Zhu
JRJean-Claude M. Rwigema
Jean-Claude M. Rwigema
XFXue Feng
Xue Feng
BABilaal Ansari
Bilaal Ansari
JDJingwei Duan
Jingwei Duan
QCQuan Chen
Quan Chen
Background/Objectives: The accurate delineation of primary tumors (GTVp) and metastatic lymph nodes (GTVn) in head and neck (HN) cancers is essential for effective radiation treatment planning, yet remains a challenging and laborious task. This study aims to develop a deep-learning-based auto-segmentation (DLAS) model trained on external datasets with false-positive elimination using clinical diagnosis reports. Methods: The DLAS model was trained on a multi-institutional public dataset with 882 cases. Forty-four institutional cases were randomly selected as the external testing dataset. DLAS-generated GTVp and GTVn were validated against clinical diagnosis reports to identify false-positive and false-negative segmentation errors using two large language models: ChatGPT-4 and Llama-3. False-positive ruling out was conducted by matching the centroids of AI-generated contours with the slice locations or anatomical regions described in the reports. Performance was evaluated using the Dice similarity coefficient (DSC), 95th percentile Hausdorff distance (HD95), and tumor detection precision. Results: ChatGPT-4 outperformed Llama-3 in accurately extracting tumor locations from the diagnostic reports. False-positive contours were identified in 15 out of 44 cases. The DSCmean of the DLAS contours for GTVp and GTVn increased from 0.68 to 0.75 and from 0.69 to 0.75, respectively, after the ruling-out process. Notably, the average HD95 value for GTVn decreased from 18.81 mm to 5.2 mm. Post ruling out, the model achieved 100% precision for GTVp and GTVn when compared with the results of physician-determined contours. Conclusions: The false-positive ruling-out approach based on diagnostic reports effectively enhances the precision of DLAS in the HN region. The model accurately identifies the tumor location and detects all false-negative errors.

21 September 2021 in Science and Technology of Nuclear Installations
Verified
Journal Article
Open access
PDF file
LZLibing Zhu
Libing Zhu
JZJianxun Zhao
Jianxun Zhao
XXXincheng Xiang
Xincheng Xiang
YZYu Zhou
Yu Zhou
XWXiangang Wang
Xiangang Wang
The geometrical shape of the TRISO-coated particle is closely related to its performance and safety. In this paper, models were set up to study the failure fraction of TRISO particle, considering the real asphericity induced by manufacturing uncertainties. TRISO is simplified as a pressure vessel model, and micro X-ray CT was employed to detect the real geometrical shape. Key geometrical parameters, thickness and volume of the real particle, were then obtained with the 3D measurement method and input into PANAMA code (a German code for fuel performance simulation). Release fraction of fission gas and failure fraction of the TRISO-coated particle were revised with the aforementioned parameters with more accuracy and compared with those of the spherical particle. Obvious increment of failure fraction of the particle is found, which may contribute to the release of fission products.

3 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
LZLibing Zhu
Libing Zhu
NYNathan Y. Yu
Nathan Y. Yu
RTRiley C. Tegtmeier
Riley C. Tegtmeier
JAJonathan B. Ashman
Jonathan B. Ashman
AAAman Anand
Aman Anand
YRYi Rong
Yi Rong
Objectives: Identifying patients’ advantageous radiotherapy modalities prior to CT simulation is challenging. This study aimed to develop a workflow using deep learning (DL)-predicted synthetic CT (sCT) for treatment modality comparison based solely on a diagnostic CT (dCT). Methods: A DL network, U-Net, was trained utilizing 46 thoracic cases from a public database to generate sCT images predicting planning CT (pCT) scans based on the latest dCT, and tested on 15 institutional patients. The sCT accuracy was evaluated against the corresponding pCT and a commercial algorithm deformed CT (MdCT) based on Mean Absolute Error (MAE) and Universal Quality Index (UQI). To determine advantageous treatment modality, clinical dose-volume histogram (DVH) metrics and Normal Tissue Complication Probability (NTCP) differences between proton and photon treatment plans were analyzed on the sCTs via concordance correlation coefficient (CCC). Results: The AI-generated sCTs closely resembled those of the commercial deformation algorithm in the tested cases. The differences in MAE and UQI values between the sCT-vs-pCT and MdCT-vs-pCT were 19.38 HU and 0.06, respectively. The mean absolute NTCP deviation between sCT and pCT was 1.54%, 0.21%, and 2.36% for esophagus perforation, lung pneumonitis, and heart pericarditis, respectively. The CCC between sCT and pCT was 0.90 for DVH metrics and 0.97 for NTCP, indicating moderate agreement for DVH metrics and substantial agreement. Conclusions: Radiation oncologists can potentially utilize this personalized sCT based approach as a clinical support tool to rapidly compare the treatment modality benefit during patient consultation and facilitate in-depth discussion on potential toxicities at a patient-specific level.